When an operation is imminent, our patients must be open about using Glucagon-like Peptide-1 receptor agonists (GLP-1 RAs) like Ozempic so we can do our part to ensure a safe and effective procedure
Other recent studies include: The American College of Cardiology 2021 Semaglutide Treatment Effect in People With Obesity STEP 1 Conclusions: Among obese patients, the GLP-1 analogue semaglutide plus lifestyle intervention was superior to placebo plus lifestyle intervention at improving weight loss. The New England Journal of Medicine 2021 Once-Weekly Semaglutide in Adults with Overweight or Obesity Conclusions: In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight. Struggling with Weight Loss Every day, millions of people around the world rely on modern medical advancements to maintain their health and well-being
Now, more Americans can access the treatments safely and affordably
Shima Hadidchi, MDs practice, we are dedicated to providing safe, effective, and personalized weight management solutions for every patient
(2026) "Product Information